The Marked Chart Wire · Business
Pfizer
Pfizer beats third-quarter earnings and raises full-year guidance
Pfizer reported third-quarter revenue of $16.58 billion and adjusted earnings per share of $0.87, both above estimates. The company raised its full-year revenue guidance to $62 billion to $64 billion and adjusted EPS to $2.95 to $3.05.
Part of a series: Pfizer wins FDA approval and beats third-quarter earnings
